hydrocortisone · Pharmacia And Upjohn · NDA 008697, 009864, 009900
Cortef
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 008697-00125 Feb 2026
Products covered · 5
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 008697 · 001 · RLD | tablet, oral | 10MG | open |
| 008697 · 002 · RLD | tablet, oral | 20MG | open |
| 008697 · 003 · RLD | tablet, oral | 5MG | open |
| 009864 · 001 · discontinued | injectable, injection | 50MG/ML | open |
| 009900 · 001 · discontinued | suspension, oral | EQ 10MG BASE/5ML | open |